CSIMarket
 


Coherus Biosciences inc   (CHRS)
Other Ticker:  
 
 

Coherus Biosciences Inc Accounts Receivables Turnover Ratio from the forth quarter 2023 to the forth quarter 2022

Quarterly Results, Trends, Rankings, Statistics


Coherus Biosciences Inc 's ability to collect accounts receivable sequentially worsen to 1.43, pointing to a challenging and on top of that deteriorating business climate for the Biotechnology & Pharmaceuticals industry. Coherus Biosciences Inc 's Average receivable collection period in the Dec 31 2023 quarter, has increased to 255 days, from 247 days, in the Sep 30 2023 quarter.

If we take a look into Healthcare sector 287 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2175, from overall ranking in the third quarter 2023 at 3425.

What is Receivable Turnover Ratio?
What is Coherus Biosciences Inc Selling?


What is Receivable Turnover Ratio?




CHRS Receivables Turnover Ratio (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Receivable Change 136.92 % 137.44 % 22.12 % -13.31 % -10.61 %
Y / Y Revenue Change 101.81 % 64.16 % -2.39 % -46.04 % -38.19 %
Receivable Turnover Ratio (TTM) 1.43 1.48 1.64 1.75 1.95
CHRS's Total Ranking # 2175 # 3425 # 3427 # 3427 # 3427
Average receivable collection period 255 246 223 208 188
Seq. Receivable Change 20.33 % 53.22 % 39.28 % -7.74 % 20.59 %
Seq. Revenue Change 22.74 % 27 % 81.02 % -28.48 % -0.16 %


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 29
Healthcare Sector # 288
Overall Market # 2175

Receivable Turnover Ratio Statistics
High Average Low
826.2 69.18 1.43
(Jun 30 2017)   (Dec 31 2023)






Financial Statements
Coherus Biosciences Inc 's Accounts Receivable $ 261 Millions Visit CHRS's Balance sheet
Coherus Biosciences Inc 's Sales TTM $ 257 Millions Visit CHRS's Income Statement
Where are CHRS's Sales coming from? Visit CHRS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CHRS's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover
Accounts Receivable Turnover for CHRS's Competitors
Receivables Turnover Ratio for CHRS's Suppliers
Accounts Receivables Turnover Ratio for CHRS's Customers

You may also want to know
CHRS's Growth Rates CHRS's Roa CHRS's Inventory Turnover Ratio CHRS's Dividend Comparisons
CHRS's Profitability Ratios CHRS's Roi CHRS's Asset Turnover Ratio CHRS's Dividend Growth
CHRS's Valuation Ratios CHRS's Roe CHRS's Financial Strength Ratios CHRS's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2023 Receivable at quarter ending Dec 31 2023
Marker Therapeutics inc   2.68 $ 3.311  Millions$ 1.235  Millions
Olink Holding Ab publ   2.62 $ 169.461  Millions$ 64.589  Millions
Regeneron Pharmaceuticals Inc   2.44 $ 13,117.200  Millions$ 5,372.925  Millions
Legend Biotech Corporation  2.39 $ 285.143  Millions$ 119.474  Millions
Ocular Therapeutix Inc   2.38 $ 58.443  Millions$ 24.550  Millions
Collegium Pharmaceutical Inc   2.37 $ 420.169  Millions$ 176.996  Millions
Smith and Nephew Plc  2.32 $ 5,549.000  Millions$ 2,395.000  Millions
Electromed Inc   2.23 $ 51.693  Millions$ 23.230  Millions
Chimerix Inc   1.83 $ 0.324  Millions$ 0.177  Millions
Intelgenx Technologies Corp   1.69 $ 1.070  Millions$ 0.632  Millions
Zymeworks Inc   1.50 $ 76.012  Millions$ 50.621  Millions
Coherus Biosciences inc   1.43 $ 257.244  Millions$ 179.950  Millions
Kamada Ltd   1.32 $ 142.519  Millions$ 108.356  Millions
Bicycle Therapeutics Plc  1.13 $ 26.976  Millions$ 23.773  Millions
Cardiff Lexington Corporation  1.13 $ 11.853  Millions$ 10.447  Millions
Profound Medical Corp   1.03 $ 7.199  Millions$ 6.989  Millions
Ac Immune Sa  1.00 $ 14.801  Millions$ 14.800  Millions
Anavex Life Sciences Corp   0.78 $ 2.576  Millions$ 3.290  Millions
Altimmune Inc   0.72 $ 0.426  Millions$ 0.594  Millions
Meiragtx Holdings Plc  0.55 $ 14.017  Millions$ 25.381  Millions
Immunitybio inc   0.32 $ 0.622  Millions$ 1.958  Millions
Inflarx N v   0.25 $ 0.071  Millions$ 0.288  Millions

Date modified: 2024-03-18T20:14:54+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com